Lyra Therapeutics, Inc. Made Headway
Lyra Therapeutics, Inc. (LYRA:NASDAQ) rocketted at $27.58, representing a gain of 36.2%. On Tue, Jun 03, 2025, LYRA:NASDAQ touched a New 2-Week High of $27.58. The stock appeared on our News Catalysts scanner on Mon, Jun 02, 2025 at 11:53 AM in the 'BIOTECH' category. From Tue, May 20, 2025, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Mon, Jun 02, 2025 at $37.5 with a volume of 26M+.
About Lyra Therapeutics, Inc. (LYRA:NASDAQ)
Lyra Therapeutics Inc a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration.
Top 10 Gainers:
- Ctrl Group Limited (MCTR:NASDAQ), 571.44%
- Smart for Life, Inc. (SMFL:NASDAQ), 300%
- NewGenIvf Group Limited (NIVF:NASDAQ), 115.12%
- Latch, Inc. (LTCH:NASDAQ), 75%
- Biomea Fusion, Inc. (BMEA:NASDAQ), 60.65%
- NuCana plc (NCNA:NASDAQ), 57.37%
- Classover Holdings, Inc. (KIDZ:NASDAQ), 46.24%
- I-Mab (IMAB:NASDAQ), 46.09%
- Kiora Pharmaceuticals, Inc. (KPRX:NASDAQ), 36.84%
- Lyra Therapeutics, Inc. (LYRA:NASDAQ), 36.2%